Sean Smith
Plus aucun poste en cours
Profil
Currently, Sean Smith occupies the position of Chief Financial Officer at Neoleukin Therapeutics, Inc.
In his past career Mr. Smith occupied the position of Senior Manager-Accounting at Aptevo Therapeutics, Inc.
Mr. Smith received an undergraduate degree and a graduate degree from the University of North Texas and an MBA from the University of Washington.
Anciens postes connus de Sean Smith
Sociétés | Poste | Fin |
---|---|---|
APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01/08/2019 |
NEUROGENE INC. | Director of Finance/CFO | - |
Formation de Sean Smith
University of Washington | Masters Business Admin |
University of North Texas | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
APTEVO THERAPEUTICS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |